Weill Cornell Medicine neuroscience team to study how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson’s disease.

Columbia University physiatrist conducts research on exercise training interventions, including balance training and aerobic exercise, for patients with spinocerebellar ataxia, a form of hereditary ataxia.

Columbia University faculty present research on a previously unknown type of immune cell in kidney tumors that can predict which patients are likely to have cancer recur after surgery.

Columbia University and Weill Cornell Medicine psychiatrists continue to investigate – in the clinic and in the lab – the potential role of ketamine in the treatment of resistant depression.

Columbia University pulmonologists conducts clinical trial on novel triple combination modulator for cystic fibrosis in patients with advanced lung disease, demonstrating progressive improvement in weight, lung function, and patient-reported outcomes.

Columbia researchers found that babies born during the pandemic’s first year scored slightly lower on a developmental screening test of social and motor skills at 6 months—regardless of whether their mothers had COVID during pregnancy—compared to babies born just before the pandemic.

COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the disease for at least three years in some patients.